Actively Recruiting
Alternate Nostril Breathing (ANB) for 1st Trimester Nausea and Vomiting
Led by University of Minnesota · Updated on 2026-03-19
100
Participants Needed
1
Research Sites
59 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a prospective, two-arm, non-blinded randomized controlled study designed to evaluate the effects of a one-week alternate nostril breathing (ANB) intervention on nausea and vomiting severity in pregnant individuals during their first trimester.
CONDITIONS
Official Title
Alternate Nostril Breathing (ANB) for 1st Trimester Nausea and Vomiting
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Pregnant individuals aged 18 years or older
- Viable pregnancy with a gestational age between 6 0/7 - 12 6/7 weeks confirmed by last menstrual period or ultrasound
- Diagnosed with mild to moderate nausea and vomiting of pregnancy (PUQE-24 score between 4-12)
- Ability to understand and read English
You will not qualify if you...
- Severe nausea and vomiting with PUQE score >12 or hyperemesis gravidarum requiring hospitalization or intravenous fluid therapy
- Pre-existing, active or acute respiratory conditions such as asthma or COPD
- History of severe anxiety disorders affecting breathing patterns
- Known deviated nasal septum
- Nausea and vomiting that started before pregnancy or caused by other conditions
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of Minnesota
Minneapolis, Minnesota, United States, 55455
Actively Recruiting
Research Team
E
Erin Wesley
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here